{"id":"https://openalex.org/W1966382437","doi":"https://doi.org/10.1080/09540121.2010.534433","title":"Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz","display_name":"Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz","alternate_titles":[],"publication_year":2011,"publication_date":"2011-04-05","ids":{"openalex":"https://openalex.org/W1966382437","doi":"https://doi.org/10.1080/09540121.2010.534433","mag":"1966382437","pmid":"https://pubmed.ncbi.nlm.nih.gov/21476152"},"language":"en","primary_location":{"id":"doi:10.1080/09540121.2010.534433","doi":"https://doi.org/10.1080/09540121.2010.534433","is_oa":false,"landing_page_url":"https://doi.org/10.1080/09540121.2010.534433","pdf_url":null,"source":{"id":"https://openalex.org/S103377564","display_name":"AIDS Care","issn_l":"0954-0121","issn":["0954-0121","1360-0451"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Care","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1966382437"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://hal.archives-ouvertes.fr/hal-00685376","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103097939","display_name":"Vanessa Cooper","orcid":"https://orcid.org/0000-0002-4525-2792","observed_orcids":["https://orcid.org/0000-0002-4525-2792"]},"institutions":[{"id":"https://openalex.org/I124357947","display_name":"University of London","ror":"https://ror.org/04cw6st05","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947"]},{"id":"https://openalex.org/I4405283614","display_name":"UCL School of Pharmacy","ror":"https://ror.org/01zna6t55","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405283614","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Vanessa Cooper","raw_affiliation_strings":["a Department of Practice and Policy, Centre for Behavioural Medicine, The School of Pharmacy , University of London , London , UK","Department of Practice and Policy, Centre for Behavioural Medicine, The School of Pharmacy , University of London , London , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a Department of Practice and Policy, Centre for Behavioural Medicine, The School of Pharmacy , University of London , London , UK","institution_ids":["https://openalex.org/I124357947","https://openalex.org/I4405283614"]},{"raw_affiliation_string":"Department of Practice and Policy, Centre for Behavioural Medicine, The School of Pharmacy , University of London , London , UK","institution_ids":["https://openalex.org/I124357947","https://openalex.org/I4405283614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054671965","display_name":"Graeme J Moyle","orcid":"https://orcid.org/0000-0002-2395-3774","observed_orcids":["https://orcid.org/0000-0002-2395-3774"]},"institutions":[{"id":"https://openalex.org/I2799869770","display_name":"Chelsea and Westminster Hospital NHS Foundation Trust","ror":"https://ror.org/02gd18467","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799869770"]},{"id":"https://openalex.org/I4210136304","display_name":"Chelsea and Westminster Hospital","ror":"https://ror.org/038zxea36","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799869770","https://openalex.org/I4210136304"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Graeme J. Moyle","raw_affiliation_strings":["b Chelsea and Westminster Hospital , HIV and Sexual Health , London , UK","Chelsea and Westminster Hospital , HIV and Sexual Health , London , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"b Chelsea and Westminster Hospital , HIV and Sexual Health , London , UK","institution_ids":["https://openalex.org/I2799869770","https://openalex.org/I4210136304"]},{"raw_affiliation_string":"Chelsea and Westminster Hospital , HIV and Sexual Health , London , UK","institution_ids":["https://openalex.org/I4210136304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050538872","display_name":"Martin Fisher","orcid":"https://orcid.org/0000-0001-5044-2585","observed_orcids":["https://orcid.org/0000-0001-5044-2585"]},"institutions":[{"id":"https://openalex.org/I4387152291","display_name":"Brighton and Sussex University Hospitals NHS Trust","ror":"https://ror.org/02dqrks84","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210151332","https://openalex.org/I4387152291"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martin Fisher","raw_affiliation_strings":["c Brighton and Sussex University Hospitals NHS Trust , Brighton , UK","Brighton and Sussex University Hospitals NHS Trust , Brighton , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"c Brighton and Sussex University Hospitals NHS Trust , Brighton , UK","institution_ids":["https://openalex.org/I4387152291"]},{"raw_affiliation_string":"Brighton and Sussex University Hospitals NHS Trust , Brighton , UK","institution_ids":["https://openalex.org/I4387152291"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089196014","display_name":"Geraldine Reilly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106787","display_name":"Gilead Sciences (United Kingdom)","ror":"https://ror.org/01e11zd27","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210106787","https://openalex.org/I4210140816"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Geraldine Reilly","raw_affiliation_strings":["d Gilead Sciences , Cambridge , UK","Gilead Sciences , Cambridge , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"d Gilead Sciences , Cambridge , UK","institution_ids":["https://openalex.org/I4210106787"]},{"raw_affiliation_string":"Gilead Sciences , Cambridge , UK","institution_ids":["https://openalex.org/I4210106787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008829104","display_name":"Jacqueline Ewan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106787","display_name":"Gilead Sciences (United Kingdom)","ror":"https://ror.org/01e11zd27","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210106787","https://openalex.org/I4210140816"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jacqueline Ewan","raw_affiliation_strings":["d Gilead Sciences , Cambridge , UK","Gilead Sciences , Cambridge , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"d Gilead Sciences , Cambridge , UK","institution_ids":["https://openalex.org/I4210106787"]},{"raw_affiliation_string":"Gilead Sciences , Cambridge , UK","institution_ids":["https://openalex.org/I4210106787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004848827","display_name":"Hui C. Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hui C. Liu","raw_affiliation_strings":["e Gilead Sciences , Foster City , CA , USA","Gilead Sciences , Foster City , CA , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"e Gilead Sciences , Foster City , CA , USA","institution_ids":["https://openalex.org/I4210140816"]},{"raw_affiliation_string":"Gilead Sciences , Foster City , CA , USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052895077","display_name":"Robert Horne","orcid":"https://orcid.org/0000-0002-3068-8438","observed_orcids":["https://orcid.org/0000-0002-3068-8438"]},"institutions":[{"id":"https://openalex.org/I124357947","display_name":"University of London","ror":"https://ror.org/04cw6st05","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947"]},{"id":"https://openalex.org/I4405283614","display_name":"UCL School of Pharmacy","ror":"https://ror.org/01zna6t55","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405283614","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rob Horne","raw_affiliation_strings":["a Department of Practice and Policy, Centre for Behavioural Medicine, The School of Pharmacy , University of London , London , UK","Department of Practice and Policy, Centre for Behavioural Medicine, The School of Pharmacy , University of London , London , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a Department of Practice and Policy, Centre for Behavioural Medicine, The School of Pharmacy , University of London , London , UK","institution_ids":["https://openalex.org/I124357947","https://openalex.org/I4405283614"]},{"raw_affiliation_string":"Department of Practice and Policy, Centre for Behavioural Medicine, The School of Pharmacy , University of London , London , UK","institution_ids":["https://openalex.org/I124357947","https://openalex.org/I4405283614"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5106411418","display_name":"for the SWEET Simplification With","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"for the SWEET (Simplification With","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5103097939"],"corresponding_institution_ids":["https://openalex.org/I124357947","https://openalex.org/I4405283614"],"apc_list":null,"apc_paid":null,"fwci":3.9069,"has_fulltext":true,"cited_by_count":53,"citation_normalized_percentile":{"value":0.93159108,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"23","issue":"6","first_page":"705","last_page":"713"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.8598999977111816,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.8598999977111816,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.12039999663829803,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.012500000186264515,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.9480000138282776},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.8420000076293945},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.3269999921321869},{"id":"https://openalex.org/keywords/zidovudine-lamivudine","display_name":"zidovudine/lamivudine","score":0.9279999732971191},{"id":"https://openalex.org/keywords/emtricitabine-tenofovir-disoproxil-fumarate","display_name":"tenofovir disoproxil fumarate/emtricitabine","score":0.9860000014305115},{"id":"https://openalex.org/keywords/efavirenz","display_name":"efavirenz","score":0.9829999804496765},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.8339999914169312},{"id":"https://openalex.org/keywords/drug-switching","display_name":"drug switching","score":0.49799999594688416},{"id":"https://openalex.org/keywords/treatment-beliefs","display_name":"treatment beliefs","score":0.5379999876022339},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9890000224113464},{"id":"https://openalex.org/keywords/viral-load","display_name":"viral load","score":0.6899999976158142}],"concepts":[{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.9232463836669922},{"id":"https://openalex.org/C2779778239","wikidata":"https://www.wikidata.org/wiki/Q422604","display_name":"Emtricitabine","level":5,"score":0.8306204080581665},{"id":"https://openalex.org/C2779465607","wikidata":"https://www.wikidata.org/wiki/Q304330","display_name":"Abacavir","level":5,"score":0.79497891664505},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.7621551752090454},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7105113863945007},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6798297762870789},{"id":"https://openalex.org/C2781390367","wikidata":"https://www.wikidata.org/wiki/Q17098321","display_name":"Intrusiveness","level":2,"score":0.6704850196838379},{"id":"https://openalex.org/C2780216070","wikidata":"https://www.wikidata.org/wiki/Q198504","display_name":"Zidovudine","level":4,"score":0.6438835859298706},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6232651472091675},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.5888949036598206},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3386140763759613},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.27337998151779175},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.2701970934867859},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.24312418699264526},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.21211087703704834},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.1854492425918579},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.09442925453186035},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C77805123","wikidata":"https://www.wikidata.org/wiki/Q161272","display_name":"Social psychology","level":1,"score":0.0},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.0},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.0},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000068679","descriptor_name":"Emtricitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000480","descriptor_name":"Alkynes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007722","descriptor_name":"Health Knowledge, Attitudes, Practice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D015215","descriptor_name":"Zidovudine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D048588","descriptor_name":"Benzoxazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D055118","descriptor_name":"Medication Adherence","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057915","descriptor_name":"Drug Substitution","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D063065","descriptor_name":"Organophosphonates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1080/09540121.2010.534433","doi":"https://doi.org/10.1080/09540121.2010.534433","is_oa":false,"landing_page_url":"https://doi.org/10.1080/09540121.2010.534433","pdf_url":null,"source":{"id":"https://openalex.org/S103377564","display_name":"AIDS Care","issn_l":"0954-0121","issn":["0954-0121","1360-0451"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Care","raw_type":"journal-article"},{"id":"pmid:21476152","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21476152","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS care","raw_type":"Clinical Trial, Phase IV"},{"id":"pmh:oai:HAL:hal-00685376v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-00685376","pdf_url":"https://hal.archives-ouvertes.fr/hal-00685376","source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"AIDS Care, 2011, 23 (06), pp.705-713. &#x27E8;10.1080/09540121.2010.534433&#x27E9;","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1351679","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/1351679/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"AIDS Care , 23 (6) pp. 705-713. (2011)","raw_type":"Article"},{"id":"pmh:oai:figshare.com:article/23400860","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Beliefs_about_antiretroviral_therapy_treatment_adherence_and_quality_of_life_in_a_48-week_randomised_study_of_continuation_of_zidovudine_lamivudine_or_switch_to_tenofovir_DF_emtricitabine_each_with_efavirenz/23400860","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:tara.tcd.ie:2262/62919","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2262/62919","pdf_url":null,"source":{"id":"https://openalex.org/S4306400387","display_name":"Trinity's Access to Research Output (TARA) (Trinity College Dublin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I205274468","host_organization_name":"Trinity College Dublin","host_organization_lineage":["https://openalex.org/I205274468"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":null}],"best_oa_location":{"id":"pmh:oai:HAL:hal-00685376v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-00685376","pdf_url":"https://hal.archives-ouvertes.fr/hal-00685376","source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"AIDS Care, 2011, 23 (06), pp.705-713. &#x27E8;10.1080/09540121.2010.534433&#x27E9;","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G6138608916","display_name":"NIHR Senior Investigator Award","funder_award_id":"NF-SI-0510-10197","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1966382437.pdf","grobid_xml":"https://content.openalex.org/works/W1966382437.grobid-xml"},"referenced_works_count":43,"referenced_works":["https://openalex.org/W140414700","https://openalex.org/W1497170016","https://openalex.org/W1533478833","https://openalex.org/W1963635045","https://openalex.org/W1963712467","https://openalex.org/W1971061593","https://openalex.org/W1971987445","https://openalex.org/W1973708179","https://openalex.org/W1974110731","https://openalex.org/W1980533403","https://openalex.org/W1992249780","https://openalex.org/W1993310507","https://openalex.org/W1994049323","https://openalex.org/W1995865755","https://openalex.org/W2008657488","https://openalex.org/W2012439934","https://openalex.org/W2027115948","https://openalex.org/W2038795551","https://openalex.org/W2044880884","https://openalex.org/W2047646906","https://openalex.org/W2058117818","https://openalex.org/W2059836477","https://openalex.org/W2063053956","https://openalex.org/W2066605334","https://openalex.org/W2086182786","https://openalex.org/W2088423598","https://openalex.org/W2089904127","https://openalex.org/W2090007886","https://openalex.org/W2104402458","https://openalex.org/W2106864136","https://openalex.org/W2109763529","https://openalex.org/W2117261241","https://openalex.org/W2127578660","https://openalex.org/W2134537454","https://openalex.org/W2141938901","https://openalex.org/W2146329405","https://openalex.org/W2164099498","https://openalex.org/W2172151487","https://openalex.org/W2318289184","https://openalex.org/W2340099473","https://openalex.org/W2407521229","https://openalex.org/W2613415461","https://openalex.org/W2938104175"],"related_works":["https://openalex.org/W2095704081","https://openalex.org/W2199088070","https://openalex.org/W2065177390","https://openalex.org/W1963712467","https://openalex.org/W4389030559","https://openalex.org/W1964825166","https://openalex.org/W7216772454","https://openalex.org/W2165006662","https://openalex.org/W2057655416","https://openalex.org/W2015240464"],"abstract_inverted_index":{"Adherence":[0,94,100],"may":[1,276],"be":[2],"facilitated":[3],"by":[4,127],"reducing":[5],"perceptual":[6,23],"and":[7,32,70,107,116,123,134,146,204,219,242,293],"practical":[8],"barriers":[9,15,24],"to":[10,41,53,84,90,229,254,274],"antiretroviral":[11],"therapy":[12],"(ART).":[13],"Practical":[14],"include":[16,25],"the":[17,28,43,98,154,169,181,247],"complexity":[18],"of":[19,27,45,72,114,156],"daily":[20],"dosing,":[21],"while":[22],"perceptions":[26],"need":[29],"for":[30],"treatment":[31,121,201,220,243,295],"concerns":[33,117,195,215,238,289],"about":[34,68,111,118,191,196,216,239,290],"adverse":[35,119,197,291],"effects.":[36],"The":[37],"study":[38,182],"aim":[39],"was":[40,95,139,165,187,233],"assess":[42],"effect":[44],"switching":[46],"zidovudine":[47],"plus":[48,57,62],"lamivudine":[49],"twice-daily":[50],"(Combivir,":[51],"CBV)":[52],"once-daily":[54],"tenofovir":[55],"DF":[56],"emtricitabine":[58],"(Truvada,":[59],"TVD),":[60],"each":[61,142],"efavirenz":[63],"(EFZ),":[64],"on":[65,77],"adherence,":[66,284],"beliefs":[67],"ART":[69,112,217,240],"quality":[71],"life":[73],"(QoL).":[74],"Subjects":[75],"stable":[76],"CBV":[78,273],"+":[79,92],"EFV":[80],"were":[81,125,223,257],"randomised":[82,269],"1:1":[83],"continue":[85],"this":[86],"regimen":[87],"or":[88,183,265],"switch":[89],"TVD":[91,170,275],"EFV.":[93],"measured":[96,126],"using":[97],"Medication":[99],"Self-Report":[101],"Inventory":[102],"at":[103,129,141],"4,":[104,131],"12,":[105,132],"24":[106,133],"48":[108,135,248],"weeks.":[109,136],"Beliefs":[110],"(perceptions":[113],"necessity":[115,192,262],"effects),":[120],"intrusiveness":[122,202,221,244],"QoL":[124,209,264],"questionnaire":[128],"baseline":[130],"Viral":[137],"load":[138,267],"assessed":[140],"visit.":[143],"Two":[144],"hundred":[145],"thirty-four":[147],"subjects":[148,157],"initiated":[149],"treatment.":[150],"At":[151,211],"week":[152,212],"48,":[153,213],"proportion":[155],"reporting":[158],"high":[159],"adherence":[160,174],"(\u226595%":[161],"taken":[162],"as":[163,178],"prescribed)":[164],"significantly":[166],"greater":[167,200,286],"in":[168,236,261,288],"arm":[171],"(p=0.049).":[172],"Low":[173],"(reporting":[175],"taking":[176],"<95%":[177],"prescribed,":[179],"discontinuing":[180],"having":[184],"missing":[185],"data)":[186],"associated":[188],"with":[189],"doubts":[190],"(p=0.020),":[193],"stronger":[194],"effects":[198,292],"(p=0.010),":[199],"(p=0.010)":[203],"poorer":[205],"mental":[206],"health":[207],"related":[208],"(p=0.008).":[210],"both":[214,237],"(p=0.038)":[218],"(p=0.004)":[222],"lower":[224],"among":[225,250],"those":[226,251],"who":[227,252],"switched":[228,253],"TVD.":[230,255],"Furthermore,":[231],"there":[232],"a":[234,285],"decline":[235],"(p=0.007)":[241],"(p=0.057)":[245],"over":[246],"weeks":[249],"There":[256],"no":[258],"significant":[259],"differences":[260],"beliefs,":[263],"viral":[266],"between":[268],"groups.":[270],"Switching":[271],"from":[272],"improve":[277],"patient":[278],"reported":[279],"outcomes":[280],"including":[281],"slightly":[282],"better":[283],"reduction":[287],"less":[294],"intrusiveness.":[296]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1966382437","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
